bioMérieux, a Durham-based biotech company, paid $90 million recently to acquire a San Diego firm that developed a test for acute kidney injury.
bioMérieux, a Durham-based biotech company, paid $90 million recently to acquire a San Diego firm that developed a test for acute kidney injury. N&O file photo
bioMérieux, a Durham-based biotech company, paid $90 million recently to acquire a San Diego firm that developed a test for acute kidney injury. N&O file photo

With $90M deal, Durham company keeps life-saving medical test in its stockpile

April 13, 2018 11:23 AM